The Institute for Pharmacology and Preventive Medicine
The Institute is an experienced partner of universities, non-university institutions, health insurance companies, and pharmaceutical companies in the implementation of scientific projects in the fields of cardiovascular disease and diabetes.
Recent Activity / Publications in press
Philipp Hillmeister, Stephanie Nagorka, Nora Gatzke, Andre Dülsner, Kangbo Li, Mengjun Li, Anja Bondke Persson, Martin A. Lauxmann, Jonnel Jaurigue, Oliver Ritter, Peter Bramlage, Eva Buschmann, Ivo Buschmann. Angiotensin converting enzyme inhibitors stimulate cerebral arteriogenesis. Acta Physiologica 2021.
Studencan M, Pella D, Bramlage P, Kaszasova E. Clinical characteristics and management of hyperlipoproteinemia in patients with chronic coronary heart disease in Slovakia. Archives of Medical Science 2021.
PubMed listed Publications